What is STAA's P/E ratio?

Staar Surgical Company (STAA) currently trades at a P/E ratio of 85.58.

Staar Surgical Company reports a Return on Equity (ROE) of -5.97%.

What is STAA's dividend yield?

Staar Surgical Company offers a dividend yield of 0.00%.

What is STAA's Quality Score?

Our AI rates STAA's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy STAA?

Our AI Timing Score for STAA is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does STAA belong to?

Staar Surgical Company is classified under the Healthcare >> Medical Instruments & Supplies sector on the NASDAQ exchange

Staar Surgical Company (STAA) Stock Price

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

STAA AI Analysis Summary

Our AI summary for STAA: Staar Surgical Company (NASDAQ), Healthcare >> Medical Instruments & Supplies sector. The stock currently trades at a P/E of 85.58, ROE of -5.97%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 26/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

STAA

Staar Surgical Company

USD 24.36

0.14 (0.58%) Day Change

Watchlist Portfolio Compare Chart

85.58

P/E

0.02

D/E

-6.0%

ROE

-4.7%

ROA

0.00%

Div Yield

4.84

PEG

STAAR SURGICAL COMPANY
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 24.36 Price 0.14 (0.58%) Day Change	NEWS SCORE: 58

STAA, the overall quality is not good ( Quality = 31) and the timing to buy is ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: P/E ratio is relatively high
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not quite good , and ability to make profit is ok , ...

Quality Factors

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	58
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	24.36
PBV / Sector	3.42 / 3.37
Earning Per Share	-0.42

PE / Sector	85.58 / 44.25
PEG or PE/Growth / Sector	4.84 / -1.35
Average 1M Daily Value	24.29 M GREAT
Average 1W Daily Value	22.95 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-7.24 / 82.17
NPM Average (%) / Sector	-5.34 / 28.91
NPM Change Average (%) / Sector	23.42 / 208.28 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-4.66 / 7.70
ROA Average (%) / Sector	-2.44 / -22.17
ROA Change Average (%) / Sector	5.37 / 105.15
ROE (%) / Sector	-5.97 / 10.10
ROE Average (%) / Sector	-3.42 / 392.40
ROE Change Average (%) / Sector	10.01 / 109.80 GOOD
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.99
Dividend Average (%) / Sector	N/A / 1.43
Dividend Change Average (%) / Sector	N/A / 11.29

Registration Details

Analyze Date	2026-08-01 08:00:32
Symbol	STAA
Name	STAAR SURGICAL COMPANY
Sector	Healthcare >> Medical Instruments & Supplies
Market	NASDAQ
Listed Shares	49.79 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	1,205.88 / 16,159.14

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 25510 Commercentre Drive, Lake Forest, CA, United States, 92630

Phone: 626 303 7902

Website: https://www.staar.com

Employees: 921

Sector: Healthcare >> Medical Instruments & Supplies

Description: STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.